Associations between serum testosterone levels, cell proliferation and progesterone receptor content in normal and malignant breast tissue in postmenopausal women

References

• Cline J M, Söderqvist G, von Schoultz E, Skoog L, von Schoultz B. Effects of hormone replacement therapy on the mammary gland of surgically postmenopausal macaques. Am J Obstet Gynecol 1996; 174: 93–100
   PubMed Web of Science ®Google Scholar
• Lundström E, Wilczek B, von Palffy Z, Söderqvist G, von Schoultz B. Mammographic breast density during hormone replacement therapy: Differences according to treatment. Am J Obstet Gynecol 1999; 181: 348–352
   PubMed Web of Science ®Google Scholar
• Santen R J, Pinkerton J, McCartney C, Petroni G R. Risk of breast cancer with progestins in combination with estrogen as hormone replacement therapy. J Clin Endocrinol Metab 2001; 86: 16–23
   PubMed Web of Science ®Google Scholar
• Weiss L K, Burkman R T, Cushing-Haugen K L, Voigt L F, Simon M S, Daling J R. Hormone replacement therapy regimens and breast cancer risk. Obstet Gynecol 2002; 100: 1148–1158
   PubMed Web of Science ®Google Scholar
• Million Women Study Collaborators: Breast cancer and hormone replacement therapy in the Million Women Study. Lancet 2003; 362: 419–427
   PubMed Web of Science ®Google Scholar
• Söderqvist G, von Schoultz B, Tani E, Skoog L. Estrogen and progesterone receptor content in breast epithelial cells from healthy women during the menstrual cycle. Am J Obstet Gynecol 1993; 168: 874–879
   PubMed Web of Science ®Google Scholar
• Soderqvist G, Isaksson E, von Schoultz B, Carlstrom K, Tani E, Skoog L. Proliferation of breast epithelial cells in healthy women during the menstrual cycle. Am J Obstet Gynecol 199; 176: 123–128
   Google Scholar
• Key T, Appleby P, Barnes I. Endogenous hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 2002; 94: 606–616
   PubMed Web of Science ®Google Scholar
• Tamimi R, Hankinson S, Chen W, Colditz G. Combined estrogen and testosterone use and the risk of breast cancer in postmenopausal women. Arch Intern Med 2006; 166: 1483–1489
   PubMed Web of Science ®Google Scholar
• Gammon M D, Thompson W D. Polycystic ovaries and the risk of breast cancer. Am J Epidemiol 1991; 134: 818–824
   PubMed Web of Science ®Google Scholar
• Lobacarro J M, Lumbroso S, Belon C, Galtier-Dereure F, Bringer J, Lesimple T, Heron J F. Male breast cancer and the androgen receptor gene. Nat Genet 1993; 5: 109–110
   PubMedGoogle Scholar
• Dimitrakakis C, Zhou J, Wang, Belanger A, Labrie F, Cheng C, Powell D, Bondy C. A physiological role for testosterone in limiting estrogenic stimulation of the breast. Menopause 2002; 10: 292–298
   Google Scholar
• Haiman C A, Brown M, Hankinson Spiegelman D, Colditz G A, Willett W C, Kantoff P W, Hunter D J. The androgen receptor CAG repeat polymorphism and risk for breast cancer in the Nurses Health Study. Cancer Res 2002; 62: 1045–1049
   PubMed Web of Science ®Google Scholar
• Isaksson E, von Schoultz E, Odlind V, Söderqvist G, Csemiczky G, Carlström K, von Schoultz B, Skoog L. Effects of oral contraceptives on breast epithelial proliferation. Breast Cancer Res Treat 2001; 65: 163–169
   PubMed Web of Science ®Google Scholar
• Conner P, Christow A, Kersemaekers W, Söderqvist G, Skoog L, Carlström K, Tani E, Mol-Arts M, Schoultz B. A comparative study on breast cell proliferation during HRT. Effects of tibolone and combined estrogen/progestogen treatment. Climacteric 2004; 7: 50–58
   Google Scholar
• Boyd N F, Lockwood G A, Byng J W, Tritchler D L, Yaffe M J. Mammographic densities and breast cancer risk. Cancer Epidemiol Biomarkers Prev 1998; 7: 1133–1144
   PubMed Web of Science ®Google Scholar
• Boyd N F, Stone J, Martin L J, Jong R, Fishell E, Yaffe M, Hammond G, Minkin S. The association of breast mitogens with mammographic densities. Br J Cancer 2002; 87: 876–882
   PubMed Web of Science ®Google Scholar
• Conner P, Svane G, Azavedo E, Söderqvist G, Carlström K, Gräser T, Walter F, von Schoultz B. Mammographic breast density, hormones and growth factors during continuous combined hormone therapy. Fertil Steril 2004; 81: 1617–1623
   PubMed Web of Science ®Google Scholar
• Hofling M, Carlström K, Svane G, Azavedo E, Klosterboer H, von Schoultz B. Different effects of tibolone and continuous combined estrogen plus progestogen hormone therapy on sex hormone-binding globulin and free testosterone levels – an association with mammographic density. Gynecol Endocrinol 2005; 20: 110–115
   PubMed Web of Science ®Google Scholar
• Lundstrom E, Soderqvist G, Svane G, Azavedo E, Olovsson M, Skoog L, von Schoultz E, von Schoultz B. Digitized assessment of mammographic breast density in patients who received low-dose intrauterine levonorgestrel in continuous combination with oral estradiol valerate: a pilot study. Fertil Steril 2006; 85: 989–995
   PubMed Web of Science ®Google Scholar
• Conner P. Hormone therapy and the breast – aspects on proliferation, apoptosis and mammographic density [dissertation]. Karolinska Institutet, Stockholm 2004; 180
   Google Scholar
• Löfgren L, Wallberg B. Wilking N, Rutqvist LE, Carlström K, von Schoultz B, von Schoultz E. Tamoxifen and megestrol acetate for postmenopausal breast cancer: diverging effects on liver proteins, androgens, and glucocorticoids. Med Oncol 2004; 21: 309–318
   PubMedGoogle Scholar
• Franzen S, Zajicek J. Aspiration biopsy in diagnosis of palpable lesions of the breast. Critical Review of 3479 consecutive biopsies. Acta Radiol Ther Phys Biol 1968; 7: 241–262
   PubMedGoogle Scholar
• Skoog L, Humla S, Isaksson S, Tani E. Immunocytochemical analysis of receptors for estrogen and progesterone in fine needle aspirates from human breast carcinomas. Diagn Cytopathol 1990; 6: 95–98
   PubMed Web of Science ®Google Scholar
• Leclercq G, Bojar H, Goussard J. Abbott monoclonal enzyme immunoassay measurement of estrogen receptors in human breast cancer: a European multicenter study. Cancer Res 1986; 46: 4233s–4236s
   PubMed Web of Science ®Google Scholar
• Södergård R, Bäckström T, Shanbag V, Carstensen H. Calculation of free and bound fractions of testosterone and estradiol-17β to plasma proteins at body temperature. J Steroid Biochem 1982; 18: 801–804
   Google Scholar
• The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group 2004 Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004; 81: 19–25
   PubMed Web of Science ®Google Scholar
• MacIndoe J H, Etre L A. An antiestrogenic action of androgens in human breast cancer cells. J Clin Endocrinol Metab 1981; 53: 836–842
   PubMedGoogle Scholar
• Ip M M, Milholland R M, Kim U. Androgen control of cytosol progesterone receptor levels in the MT-W9B transplantable tumor in the rat. J Natl Cancer Inst 1982; 69: 673–681
   PubMedGoogle Scholar
• Conner P, Söderqvist G, Skoog L, Gräser T, Walter T, Tani E, Carlström K, von Schoultz B. Breast cell proliferation in postmenopausal women during HRT evaluated through fine needle aspiration biopsy. Breast Cancer Res Treat 2003; 78: 159–165
   PubMed Web of Science ®Google Scholar
• Lundström E, Wilczek B, von Palffy Z, Söderqvist G, von Schoultz B. Mammographic breast density during hormone replacement therapy: effects of continuous combination, unopposed transdermal and low-potency estrogen regimens. Climacteric 2001; 4: 42–48
   PubMedGoogle Scholar
• Lundström E, Christow A, Kersemaekers W, Svane G, Azavedo E, Söderqvist G, Mol-Arts M, Barkfeldt J, von Schoultz B. Effects of tibolone and continuous combined hormone replacement therapy on mammographic breast density. Am J Obstet Gynecol 2002; 186: 717–722
   PubMed Web of Science ®Google Scholar
• Battersby S, Robertson B J, Anderson T J, King R J, McPherson K. Influence of menstrual cycle, parity and oral contraceptive use on steroid hormone receptors in normal breast. Br J Cancer 1992; 65: 601–607
   PubMed Web of Science ®Google Scholar
• Dabrosin C. Positive correlation between estradiol and vascular endothelial growth factor but not fibroblast growth factor-2 in normal human breast tissue in vivo. Clin Cancer Res 2005; 11: 8036–8041
   PubMed Web of Science ®Google Scholar
• Clarke R B. Ovarian steroids and the human breast: regulation of stem cells and cell proliferation. Maturitas 2006; 54: 327–334
   PubMed Web of Science ®Google Scholar